CLINICAL_TRIALS
trial_result
· 2022-06-06
Clinical Trial Update: Omalizumab Efficacy in Patients With Refractory Nasal Polyps [Phase 4]
Summary
Phase 4 trial update evaluating the efficacy of omalizumab in patients with refractory nasal polyps.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shiraz University of Medical Sciences | Conditions: Nasal Polyps | Phase 4 | Status: UNKNOWN